Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000912282-25-000932
Filing Date
2025-08-27
Accepted
2025-08-27 17:10:09
Documents
1
Period of Report
2025-08-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3407
  Complete submission text file 0000912282-25-000932.txt   5014
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REZOLUTE, INC. 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address
Karnawat Sunil Ratilal (Reporting) CIK: 0002083506 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39683 | Film No.: 251266362